1. Home
  2. ELUT vs PRPO Comparison

ELUT vs PRPO Comparison

Compare ELUT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • PRPO
  • Stock Information
  • Founded
  • ELUT 2015
  • PRPO N/A
  • Country
  • ELUT United States
  • PRPO United States
  • Employees
  • ELUT N/A
  • PRPO N/A
  • Industry
  • ELUT Medical Specialities
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ELUT Health Care
  • PRPO Industrials
  • Exchange
  • ELUT Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • ELUT 38.2M
  • PRPO 32.4M
  • IPO Year
  • ELUT 2020
  • PRPO N/A
  • Fundamental
  • Price
  • ELUT $0.66
  • PRPO $26.76
  • Analyst Decision
  • ELUT Strong Buy
  • PRPO
  • Analyst Count
  • ELUT 2
  • PRPO 0
  • Target Price
  • ELUT $7.00
  • PRPO N/A
  • AVG Volume (30 Days)
  • ELUT 224.2K
  • PRPO 12.7K
  • Earning Date
  • ELUT 11-06-2025
  • PRPO 11-14-2025
  • Dividend Yield
  • ELUT N/A
  • PRPO N/A
  • EPS Growth
  • ELUT N/A
  • PRPO N/A
  • EPS
  • ELUT N/A
  • PRPO N/A
  • Revenue
  • ELUT $21,746,000.00
  • PRPO $22,800,000.00
  • Revenue This Year
  • ELUT $1.90
  • PRPO N/A
  • Revenue Next Year
  • ELUT $6.37
  • PRPO N/A
  • P/E Ratio
  • ELUT N/A
  • PRPO N/A
  • Revenue Growth
  • ELUT 24.08
  • PRPO 30.95
  • 52 Week Low
  • ELUT $0.66
  • PRPO $3.90
  • 52 Week High
  • ELUT $5.12
  • PRPO $27.29
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 18.44
  • PRPO 76.74
  • Support Level
  • ELUT $0.69
  • PRPO $18.50
  • Resistance Level
  • ELUT $0.77
  • PRPO $21.00
  • Average True Range (ATR)
  • ELUT 0.06
  • PRPO 1.57
  • MACD
  • ELUT -0.01
  • PRPO 0.42
  • Stochastic Oscillator
  • ELUT 0.09
  • PRPO 91.01

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: